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Background. Acute biliary diseases during pregnancy have been classically managed conservatively. Advances in minimally
invasive surgery and the high recurrence rate of symptoms observed changed this management. Methods. This is a prospective
observational study. Initial management was medical. Unresponsive patients were treated with minimally invasive techniques
including gallbladder percutaneous aspiration or cholecystostomy, endoscopic retrograde cholangiography, and laparoscopic
cholecystectomy, depending on the pregnancy trimester and underlying diagnosis. Results. 122 patients were admitted. 69 (56.5%)
were unresponsive to medical treatment. Recurrent gallbladder colic was the most frequent indication for minimally invasive
intervention, followed by acute cholecystitis, choledocholithiasis, and acute biliary pancreatitis. 8 patients were treated during
the ﬁrst trimester, 54 during the second, and 7 during the last trimester. There was no fetal morbidity or mortality. Maternal
morbidity was minor with no mortality. Conclusion. Acute biliary tract diseases during pregnancy may be safely treated with
minimally invasive procedures according to the underlying diagnosis and to the trimester of pregnancy.
Copyright © 2009 Luis Tom´ as Chiappetta Porras et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Symptomatic biliary tract disease during pregnancy has been
traditionally managed conservatively, leaving surgery for
treatment failures. A recent report suggests that fetal death
rate is higher after conservative treatment than after laparo-
scopic cholecystectomy for symptomatic benign biliary dis-
ease [1]. Recurrence rates after conservative treatment seem
to be trimester depending and range between 40–92% [1, 2].
Surgical advances made over the last two decades shifted
the management towards a multidisciplinary and minimally
invasive approach. Interventional radiology, endoscopic ret-
rograde cholangiography (ERCP), and laparoscopic surgery
are commonly employed, but their timing and indications
need to be properly deﬁned
The objective of this study is to analyze the results
obtained with a minimally invasive protocol to treat patients
with acute biliary tract disease during pregnancy.
2.MaterialandMethods
From January 1998 through January 2008 all patients with
acute benign biliary tract disease during pregnancy were
enrolled in a prospective treatment protocol. Inclusion diag-
noses were gallbladder colic, cholecystitis, choledocholithia-
sis, and acute biliary pancreatitis.
Exclusion criteria were as follows.
(i) Severe cardiac disorders such as congestive heart fail-
ure,diagnosisofunstableangina,oracutemyocardial
infarction.
(ii) Severe impairment of renal function requiring dialy-
sis.
(iii) Coagulopathy or medical aﬀection requiring antico-
agulation.2 HPB Surgery
(iv) Mental incapacity, unwillingness, or language barri-
ers precluding adequate understanding or coopera-
tion or compromises the ability of the subject to give
written informed consent.
All diagnoses were made with a combination of medical
history and physical examination, laboratory tests (such as
amylase in the case of acute pancreatitis) and ultrasonogra-
phy.Diagnosisofgallbladdercolicwasmadewiththecombi-
nation of biliary pain in the presence of gallbladder lithiasis
and in the absence of ultrasonographic signs of gallbladder
inﬂammation. Diagnosis of acute cholecystitis was made
when biliary pain was associated with the presence of both
gallbladder lithiasis and inﬂammation (wall edema, gallblad-
der distension, etc.). Acute biliary pancreatitis was deﬁned
with the presence of biliary pain, elevated serum amylase,
presence of gallbladder lithiasis, and ultrasonographic signs
of pancreatic inﬂammation. Choledocholithiasis was deﬁned
with the presence of biliary symptoms, jaundice, abnormal
liver function tests, presence of gallbladder lithiasis and a
common bile duct diameter greater than 7mm.
All patients were initially managed conservatively. Con-
servative management varied according with the admission
diagnosis. Patients unresponsive or relapsing after medical
treatment were considered conservative treatment failures
and were treated using minimally invasive procedures.
Pregnant patients presenting with recurrent gallbladder
colic during the ﬁrst or third trimester were managed
with percutaneous gallbladder aspiration. Patients present-
ing with acute cholecystitis during the same period of
pregnancy were treated with percutaneous cholecystostomy.
Thosepatientspresentingwithbiliaryobstructionduringthe
ﬁrst or third trimester of pregnancy were initially managed
with ERCP. Deﬁnitive treatment in all cases was done at
the postpartum period with laparoscopic cholecystectomy
and single stage management of choledocholithiasis when
required, following a protocol previously described [3].
During the second trimester of pregnancy (13◦ to 33◦
week) patients were managed with laparoscopic surgery.
SAGES guidelines [4] were strictly followed and included
pneumatic compression of the lower extremities, peropera-
tive fetal monitoring, intraoperative maternal oxicapnogra-
phy, uterine protection with a lead shield, open-access neu-
moperitoneum and working pressures between 8 and 12mm
Hg. Uterine inhibition with ritodrine was administered to all
patients for the ﬁrst 36 hours.
All patients received adequate information regarding
signs and symptoms of possible complications or relapse
of their pathology and were strongly counseled to visit the
hospital for consultation. Additional information provided
by the nutritionist was given, in order to avoid certain foods
that could be responsible for new symptomatic episodes.
The local ethics committee approved the protocol and all
patients signed an informed consent prior to their inclusion
in the present study.
3. Results
A total of 122 patients were enrolled in the treatment pro-
tocol. Admission diagnoses were recurrent gallbladder colic
in 55 cases, acute cholecystitis in 41, bile duct obstruction
in 18, and acute biliary pancreatitis in 8.75% of patients
were admitted initially at our hospital and 25% were referred
from other institutions. All patients were referred after initial
consultation to the emergency department. Mean age was 24
years (range 15–39 years).
Conservative treatment failure occurred in 69 patients
(56.5%). 8 patients were treated during the ﬁrst trimester of
pregnancy of whom 4 with acute cholecystitis were treated
with percutaneous cholecystostomy, 3 admitted because of
recurrent gallbladder colics were treated with percutaneous
gallbladder aspiration with symptomatic relief in all of them
and one patient with acute biliary pancreatitis was treated
with ERCP removing 2 bile duct stones. 54 patients were
admitted during the second trimester of pregnancy and
were treated with laparoscopic surgery. Mean gestational
age was 24.6 weeks. Admission diagnoses were recurrent
gallbladder colic in 20 cases, acute cholecystitis in 17, bile
duct obstruction in 12 and acute biliary pancreatitis in
5. All cases underwent laparoscopic cholecystectomy with
intraoperative cholangiography; 21 (39%) had common bile
duct stones. 16 were successfully treated with a transcys-
tic approach and the remaining 5 required laparoscopic
choledocotomy because of multiple bile duct stones. After
complete bile duct clearance all these cases were ﬁnished
withprimaryductclosure.Meanhospitalizationtimewas1.8
days (range 1–3 days) for laparoscopic cholecystectomy and
3 days (range 2–4 days) for common bile duct exploration.
7 patients were treated in the last trimester. 3 required
ERCPwithstentplacementbecauseofmultiplecommonbile
duct stones. 3 required percutaneous gallbladder aspiration
becauseofrecurrentgallbladdercolicsand1becauseofacute
cholecystitis. 96.5% of patients were followed for a medium
time of 60 months (range 2–120 months). There were no
fetal morbidity or mortality. Maternal morbidity included 2
minor wound infections after laparoscopic surgery managed
with oral antibiotics in an outpatient basis. There was no
maternal mortality.
4. Discussion
Acute benign biliary diseases and acute appendicitis are the
most common surgical indications during pregnancy [5].
Swisher et al. [2] demonstrated that the risk of symptoms
recurrence after successful medical treatment for acute
biliary diseases was 92% in the ﬁrst trimester, 64% in the
secondtrimester,and44%inthelastone.Recurrentepisodes
of biliary pancreatitis were observed in 50% of patients after
conservative treatment [6]. In Ghummann’s series [7] the
most common cause of biliary surgery during pregnancy
were repeated biliary colic in 70% of cases, followed by
acute cholecystitis in 20%, choledocholithiasis in 7% and
acute biliary pancreatitis in the remaining 3% of cases. In
the present series the most common cause of surgery was
also recurrent biliary colic with 37.5%, followed by acute
cholecystitis with 32% of cases.
At the beginning of laparoscopic era, cholecystectomy
during pregnancy was considered as a relative contraindi-
cation, mainly because of the lack of knowledge of theHPB Surgery 3
eﬀects of CO2 to the fetus. Fear of surgical treatment was
based on the potential risk of abortion or malformations
if done during the ﬁrst trimester or preterm labor when
done in the last one. It is therefore recommended treatment
during these periods to be done with percutaneous or
endoscopictechniques.Today,thereisunanimousagreement
concerning the security of laparoscopic cholecystectomy
during the second trimester of pregnancy and some extent
the indication to the ﬁrst and third trimester too [7–
11]. However, our protocol includes laparoscopic surgery
only during second trimester, using minimally invasive
techniques such as ERCP, percutaneous cholecystostomy or
percutaneous gallbladder aspiration for patients in the ﬁrst
or second trimester. The absence of morbidity and mortality
with these techniques in our series is similar as reported by
others [12, 13].
Potential risks of laparoscopic surgery during pregnancy
are uterine lesion during trocar placement, induction of
preterm labor and fetal acidosis, among many others.
Peroperative fetal monitoring as indicated in SAGES guide-
lines is extremely important in preventing the last two
potential complications mentioned. However, a recent study
by Lu et al. [14] reports a higher incidence of spontaneous or
induced preterm labor for patients with conservative versus
surgical treatment, with a clear relation with symptoms
recurrence. Even though the risks to the fetus during
the second trimester for radiation exposure are low, it is
recommended to protect the uterus with a lead shield.
Similarly, working pressures of CO2 are recommended to be
below 12mmHg in order to prevent fetal acidosis [4].
Known beneﬁts of laparoscopic surgery are the lower
necessity of narcotic use in the postoperative period, a lower
risk of wound-related complications, and a faster return to
ambulation and oral intake, among many others. Curet et al.
[5] support this in pregnant patients, demonstrating a
signiﬁcant reduction in hospitalization time for laparoscopic
cases in comparison between open and laparoscopic chole-
cystectomy, although this was a retrospective one, with the
inheriting biases of this kind of studies.
In conclusion, our results suggest that laparoscopic
cholecystectomywithorwithoutbileductexplorationcanbe
carriedoutsafelyinpregnantpatients withacutebiliarytract
diseases unresponsive to medical treatment between weeks
13–33. Patients during the ﬁrst or ﬁnal trimester should
be treated with less invasive procedures such as endoscopic
or percutaneous techniques. These results might allow us
to change the original protocol and now patients treated
with endoscopic or percutaneous techniques during the ﬁrst
trimester could be deﬁnitively managed with laparoscopic
cholecistectomy in the second trimester instead of waiting
until the postpartum period.
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